Regulatory Support for Cancer Prevention Agent Development

本合同的目的是为国家癌症研究所（NCI）的癌症预防部门（DCP）提供监管服务和技术支持。本合同将准备和维护美国食品药品监督管理局（FDA）和其他监管机构要求的用于研究药物临床试验的文件。 需要技术支持来收集、解释和总结与潜在癌症预防药物相关的临床前和临床数据。

The purpose of this contract is to provide regulatory services and technical support to the Division of Cancer Prevention (DCP) at the National Cancer Institute (NCI). This contract will prepare and maintain documents required by the Food and Drug Administration (FDA) and other regulatory bodies for clinical trials of investigational agents. Technical Support is required to gather, interpret and summarize the preclinical and clinical data associated with potential cancer preventive agents.